Articles filed under 'MEN’S HEALTHCARE'
Lose Weight with CoffeeROASTeHe states in his article that not only have studies found statistically lower rates of several other cancers in coffee drinkers, including breast, prostate, esophagus, mouth and throat, but dental cavities and even gout are…
Continue Reading
March 7th, 2011
|
Former Fremonter writes articles, blogs and a book on fatherhoodFremont TribuneFive years ago, Higley, then 44, was diagnosed with early stage prostate cancer. "They caught it by accident. I had zero symptoms," he said, adding, "I was extremely lucky. My oncologist and surgeon said I probably would have been dead within a year …
|
Continue Reading
March 5th, 2011
|
Exelixis Shares Popped: What You Need to KnowMotley FoolMore importantly, and probably a bigger reason for the move, was the overview on prostate cancer drug cabozantinib that management provided in the earnings call. Now what: In short, the cabo information is nothing but great news. …
and more »
|
Continue Reading
March 4th, 2011
|
Obesity, some cancers linkedLas Vegas Review-JournalFurther, a 2007 NCI study looked at prostate cancer and obesity. Done in cooperation with the American Association of Retired Persons, the study involved nearly 287000 males aged 50 to 71 between 1995 and 2001. The report found that in that time, …
and more »
|
Continue Reading
March 2nd, 2011
|
When Will Dendreon Make Money?Motley FoolIts current manufacturing facility is running at full capacity, but the company expects to increase manufacturing of its prostate cancer treatment, Provenge, tenfold over the next year. Dendreon should hear from the Food and Drug Administration about …
and more »
|
Continue Reading
March 2nd, 2011
Continue Reading
March 2nd, 2011
Former Fremonter writes articles, blogs and a book on fatherhoodFremont TribuneFive years ago, Higley, then 44, was diagnosed with early stage prostate cancer. "They caught it by accident. I had zero symptoms," he said, adding, "I was ex…
Continue Reading
March 1st, 2011
Continue Reading
February 26th, 2011
|
This Week's 5 Smartest Stock MovesMotley FoolLater this year, Exelixis will begin testing its prostate cancer drug cabozantinib as a possible treatment for other types of cancer. Vertex's VX-770 received positive data from a drug trial, showing improved lung function in some patients with cystic …
and more »
|
Continue Reading
February 26th, 2011
Continue Reading
February 25th, 2011
Previous Posts